These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7415992)

  • 1. Effects of disopyramide on systemic and coronary hemodynamics and myocardial metabolism in patients with coronary artery disease: comparison with lidocaine.
    Kötter V; Linderer T; Schröder R
    Am J Cardiol; 1980 Sep; 46(3):469-75. PubMed ID: 7415992
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of intravenous disopyramide on the hemodynamics of patients hospitalized in intensive care units].
    Boland J; Lisin N; Marcelle R; Carlier J
    Arch Int Pharmacodyn Ther; 1976 Nov; 224(1):145-51. PubMed ID: 1015909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative effects of disopyramide and lidocaine on negative inotropic action--evaluation by multigated RI angiography (author's transl)].
    Kito Y; Fujita T; Kosakai Y; Naito Y; Koyanagi H; Ohara K; Ego Y; Hayashi K; Manabe H; Nishimura T; Kozuka T
    Kokyu To Junkan; 1981 Apr; 29(4):405-10. PubMed ID: 7255990
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of lidocaine on systemic and coronary hemodynamics.
    Thomsen JH; Terry W; Stenlund RR; Querimit S; Rowe GG
    Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):83-92. PubMed ID: 5123869
    [No Abstract]   [Full Text] [Related]  

  • 5. Haemodynamics of intravenous disopyramide.
    Sutton R
    J Int Med Res; 1976; 4(1 Suppl):46-8. PubMed ID: 1026528
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulatory effects of intravenous disopyramide in heart failure.
    Jensen G; Uhrenholt A
    J Int Med Res; 1976; 4(1 Suppl):42-5. PubMed ID: 1026527
    [No Abstract]   [Full Text] [Related]  

  • 7. Disopyramide and lignocaine. A comparison of cardiac effects using echocardiography.
    Martin MA; Bax ND; Tucker GT; Ward JW
    Br J Clin Pharmacol; 1980 Sep; 10(3):237-44. PubMed ID: 7437240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous disopyramide in myocardial infarction: a haemodynamic study.
    Marrott PK; Nairn PL; Hill PD; Turner G; Sharman J
    N Z Med J; 1983 Jan; 96(723):4-7. PubMed ID: 6571755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of adenosine on myocardial hemodynamics and metabolism after coronary artery bypass grafting (CABG).
    Zäll S; Milocco I; Ricksten SE
    J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):30. PubMed ID: 2520967
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of hemodynamic and coronary effects induced by intravenous injection of disopyramide administered to coronary failure and congestive heart failure patients (author's transl)].
    Pornin M; Roland E; Lardoux H; Sellier P; Morin D; Ourbak P; Maurice P
    Therapie; 1981; 36(2):179-86. PubMed ID: 7292392
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative haemodynamic effects of lidocaine, mexiletine, and disopyramide.
    Beltrame J; Aylward PE; McRitchie RJ; Chalmers JP
    J Cardiovasc Pharmacol; 1984; 6(3):483-90. PubMed ID: 6202976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral disopyramide therapy on left ventricular function.
    Greene AC; Iskandrian AS; Hakki AH; Kane SA; Segal BL
    Chest; 1983 Mar; 83(3):480-4. PubMed ID: 6825481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electrophysiologic and hemodynamic effects of disopyramide phosphate (author's transl)].
    Suzuki S; Kasanuki H; Onishi S; Tanaka T; Hirosawa K; Tanaka T; Abe M; Kohashi K; Taniguchi T; Matsuda M
    Kokyu To Junkan; 1981 Oct; 29(10):1079-84. PubMed ID: 6800004
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemodynamic evaluation of the action of calcium antagonists].
    Vincenzi M; Allegri P; Barbieri E; Cappelletti F; Carrozza A; De Lio U; Maiolino P; Morlino T; Ometto R
    Boll Soc Ital Cardiol; 1978; (1 Suppl):79-97. PubMed ID: 757682
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular effects of a newer antiarrhythmic agent, disopyramide phosphate.
    Mathur PP
    Am Heart J; 1972 Dec; 84(6):764-70. PubMed ID: 4150336
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemodynamic and electrocardiographic effects of intravenous disopyramide (rythmodan) following acute myocardial infarction.
    Davies GJ; Marrott PK; Muir JR
    Br J Clin Pharmacol; 1979 Feb; 7(2):183-7. PubMed ID: 760751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic and electrocardiographic effects of disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    Acta Med Scand; 1976; 199(1-2):41-51. PubMed ID: 1251772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of nitroglycerin and isosorbiddinitrate on myocardial perfusion and hemodynamics in patients with and without coronary disease.
    Simon R; Amende I; Engel HJ; Lichtlen PR
    Scand J Clin Lab Invest Suppl; 1984; 173():47-58. PubMed ID: 6442002
    [No Abstract]   [Full Text] [Related]  

  • 19. Haemodynamic effects of intravenous disopyramide in heart failure.
    Jensen G; Sigurd B; Uhrenholt A
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):167-73. PubMed ID: 1233215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of nitroglycerin on left ventricular circulation and ejection fraction in patients with anatomo-functional involvement of the ventricular myocardium].
    Manfroi WC; de Freitas FM
    Arq Bras Cardiol; 1982 Nov; 39(5):315-20. PubMed ID: 6821149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.